The coevolution of firms and their knowledge environment: Insights from the pharmaceutical industry

What are the most effective learning strategies for firms given the characteristics of their knowledge environment? This paper addresses this question by documenting the major changes in the knowledge environment of the pharmaceutical industry, with a particular emphasis on the period since the emergence of biotechnology, and discussing the related changes in the learning strategies of established pharmaceutical firms. Both the historical analysis and a review of the empirical research on organizational learning and knowledge transfer reveal a strong emphasis of firms on external learning through interfirm collaborations and sourcing of external knowledge. This learning strategy seems to be driven by the speed, uncertainty, and dispersion of knowledge developments in the industry. Studying the connections between the knowledge environment and the effectiveness of organizational learning processes is important to understand organizational change and adaptation, and is an area of research that deserves further attention.     

A research note on market creation in the pharmaceutical industry

When a firm launches a market-creating innovation, it launches a new product for which there are no close product substitutes. Thus, the new product causes a shift in the existing product-market structure of an industry. This paper reports on the findings of the analysis of 51 large pharmaceutical firms and their market-creating activities. The study suggests that market-creating firms have capabilities in both R&D and marketing. Furthermore, market-creating firms enjoy stronger efficiencies, manage costs better and make more profitable use of their assets.     

医药类上市公司会计政策选择研究

会计政策选择能否恰当,直接影响着企业所提供的会计信息质量,进而影响外部信息使用者的决策。文章以沪深两市医药类上市公司2011到2013连续三年的会计年报的数据为样本,统计分析了医药类上市公司会计政策的选择情况和存在的问题,对规范医药类上市公司会计政策选择提出了相关对策。     

市场势力、资产专用性与企业研发投入:来自卖方与买方双维度考量的实证研究

在纵向关联市场中,市场势力和资产专用性是企业创新研发投入的重要影响因素。基于2012-2016年我国121家医药制造业上市公司微观数据,从买方与卖方双重视角探究市场势力、资产专用性与企业创新研发投入的关系。结果表明：买方势力、卖方势力与企业研发投入之间均呈现“倒U型”关系,即当买卖双方市场势力较小时,市场势力对企业研发投入的正向“激励效应”占主导地位;在市场势力超过一定水平后,市场势力对企业研发投入的负向“挤出效应”占主导地位,且相比于专用性资产投资强度较低的医药企业而言,卖方势力与买方势力对具有高资产专用性强度的医药企业研发投入所产生的“倒U型”影响更为显著。     

基于科学的产业发展影响因素组态与路径研究——对中国内地31省份医药制造业的QCA分析

基于科学的产业在经济发展中具有极强的活力,正成为21世纪国家经济发展的新引擎和新一轮产业革命的摇篮。选择医药制造业作为科学产业的典型案例,以我国内地31个省份数据为研究样本,运用模糊集定性比较分析(fsQCA)方法,探讨经济、科学、技术、政策条件对科学产业发展绩效的联动效应及路径选择。结果表明,单一条件并不构成制药业高绩效的必要条件,前因条件多重并发形成驱动制药业高绩效的多样化组态;存在驱动制药业高水平绩效的3条路径,分别是科学与技术双元主导驱动型、经济主导逻辑下的科学与政策驱动型以及经济主导逻辑下的技术与政策驱动型;存在导致制药业非高水平绩效的两条路径,且这两个组态的核心条件相同,即非经济水平和非科学研究。结论有助于深化对我国科学产业发展背后多重因素间复杂互动本质的理性认识,并为基于科学的产业成长带来有益的实践启示。     

国产品牌降压药北京地区医院营销策略研究

通过设计定量研究分析方案，根据调查结果，了解影响降压药在医院推广的相关因素，包括医生的处方行为和使用习惯；医生决策过程和驱动因素等，以期为我国国产品牌降压药品在北京地区医院的推广提出建议.     

制药企业选择CRO的指标分析

本文提出了制药企业选择CRO的指标,并简述了指标权重确定的步骤,为制药企业选择CRO提供指标上的参考。     

Plant level performance measurement: an exploratory case study of a pharmaceutical encapsulation company

Over the last few decades, hundreds of books and articles have been written on performance measures in manufacturing companies. A good number of those works has focused on overall organizational performance at the corporate level, business unit performance, and individual performance. Barring a few studies, there has been very little work reported on what specific performance measures are used at the plant and department level at a manufacturing facility. This exploratory research, through a case study of a pharmaceutical encapsulation company addresses those issues. Results show that the managers use a wide variety of measures primarily for meeting corporate targets and implementing a gain-sharing plan. There are not many common measures of performance used by managers for decision-making. None of the managers specifically linked the performance measures to the competitive priorities of the products made at the plant. A few propositions and suggestions for future research are made in the paper.